An Open Label Single Arm Clinical Study to Evaluate the Combined Effectiveness of Oral Administration of Abhayarishta Churna and Aragwadha Patra Lepa in Kitibha Kushta (Psoriasis)
Abstract
Kitibha Kushta is a Raktapradoshaja Vikara where it is categorised under Kshudra Kushta. Acharya Charaka mentioned the involvement of Vata and Kapha in Kitibha Kushta and is compared with Psoriasis due to close resemblance of its symptoms. Psoriasis is a chronic inflammatory, non-communicable, painful, disfiguring, disabling, and hyperproliferative skin disease. It is a chronic, non-communicable, proliferative auto-immune skin disease affecting 2% of world population. The prevalence of psoriasis ranges between 0.09% and 11.4% in different populations around the world, making it a serious global concern. In India, the prevalence of psoriasis varies from 0.44 to 2.8%, According to Global Psoriasis Atlas (GPA) an estimated 3.59 million people in India and 100 million people world-wide are affected. Objectives of the study: To evaluate the combined effectiveness of Abhayarishta Churna and Aragwadha Patra Lepa in management of Kitibha Kushta (Psoriasis). Material & Methods: A total of 30 participants of either gender were included in the study using the random sampling method. Among 33 registered participants, 30 completed the course of study. They were administered with Abhayarishta Churna 6 grams twice a day after food with Anupana of Madhu for 30 days in combination with Aragwadha Patra Lepa application externally. Lakshanas of Kitibha Kushta were assessed as primary outcome measures and the PASI score was assessed as the secondary outcome. For statistical analysis, subjective parameters were assessed with Friedman’s test, Wilcoxon sign rank test. Objective parameters were assessed by Repeated Measures ANOVA. Results: Statistically significant improvement was observed in the primary and secondary outcome measures of Kitibha Kushta (Psoriasis). Conclusion: Combination of Abhayarishta Churna and Aragwadha Patra Lepa was found to be effective in the management of Kitibha Kushta (Psoriasis).
Downloads
References
Agnivesha, Charaka. Chikitsa Sthana, Kustha Chikitsa (Chapter 7, Verse 13-14). In: Shukla V, Tripathi R, editors. Charaka Samhita. 1st ed. Delhi: Chaukhamba Sanskrit Pratishthan; 2010. Vol. I, p. 182-183.
Sharma PV. Sushruta Samhita with Nibandhasangraha commentary of Dalhanacharya. Varanasi: Chaukhamba Orientalia; 2002 (Reprint). Sutra Sthana 24/6, p. 114.
Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475.
Harden L, Kreuger G, Bowcock AM. Immunogenetics of psoriasis: a comprehensive review. J Autoimmun. 2015;64:66-73. Christophers E. Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314–320. doi:10.1046/j.1365-2230.2001.00832.x.
Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010: Results by Cause, 1990-2010. Seattle: IHME; 2012.
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321–328. doi:10.1007/s00403-006-0703-z.
Gibbs S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol. 1996;35(9):633-9.
Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013;168:1303-10.
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76:595-601.
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35. doi:10.1186/1477-7525-4-35.
Sharma PV. Sushruta Samhita with Nibandhasangraha commentary of Dalhanacharya. Varanasi: Chaukhamba Orientalia; 2002 (Reprint). Sutra Sthana 33/5, p. 144.
Agnivesha, Charaka. Chikitsa Sthana, Kustha Chikitsa (Chapter 7, Verse 37). In: Shukla V, Tripathi R, editors. Charaka Samhita. 1st ed. Delhi: Chaukhamba Sanskrit Pratishthan; 2010. Vol. I, p. 186.
Sushruta, Dalhana, Shrigayads. Nidana Sthana, Kushta Nidana (Chapter 5). In: Thakaral KK, translator. Sushruta Samhita. 2nd ed. Varanasi: Chaukhamba Orientalia; 2016. Part-1, p. 760.
Bhavamishra. Purva Khanda, Haritakyadi Varga (Chapter 6(2), Verse 19-26). In: Bulusu S, commentator. Bhavaprakash. Reprint ed. Varanasi: Chaukhamba Orientalia; 2018. Vol. I, p. 131-133.
Bhavamishra. Purva Khanda, Guduchyadi Varga (Chapter 6(4), Verse 93-96). In: Bulusu S, commentator. Bhavaprakash. Reprint ed. Varanasi: Chaukhamba Orientalia; 2018. Vol. I, p. 251-252.
Bhavamishra. Purva Khanda, Haritakyadi Varga (Chapter 6(2), Verse 148-150). In: Bulusu S, commentator. Bhavaprakash. Reprint ed. Varanasi: Chaukhamba Orientalia; 2018. Vol. I, p. 160-161.
Hegde PL, Harini A. A textbook of Dravya Guna Vijnana, Aragwadha (Chapter 6). Vol-2, Revised ed. New Delhi: Chaukhamba Publications; 2020. p. 41-45.
Agnivesha, Charaka. Chikitsa Sthana, Kustha Chikitsa (Chapter 7, Verse 13-14). In: Shukla V, Tripathi R, editors. Charaka Samhita. 1st ed. Delhi: Chaukhamba Sanskrit Pratishthan; 2010. Vol. I, p. 182-183.
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76:595-601.
Sharangadhara. Madhyama Khanda, Churna Nirmana Vidhi (Chapter 6, Verse 1-4). In: Tripathi B, editor. Sharangadhara Samhita, Dipika Hindi Commentary. Varanasi: Chaukhamba Surharati Prakashan; 2004. p. 172-173.
Govinda Das. Kushta Chikitsa Prakarana (Chapter 54, Verse 60). In: Shastri A, Shastri R, editors. Bhaishajya Ratnavali. 14th ed. Varanasi: Chaukhamba Sanskrit Samsthana; 2001. p. 622.
Govinda Das. Kushta Chikitsa Prakarana (Chapter 54, Verse 20). In: Shastri A, Shastri R, editors. Bhaishajya Ratnavali. 14th ed. Varanasi: Chaukhamba Sanskrit Samsthana; 2001. p. 616.
Sharangdhara. Uttarakhanda, Alepa Naama Tatha Parinama (Chapter 11, Verse 1-2). In: Mishra D, editor. Sharangadhara Samhita. Varanasi: Chaukhamba Sanskrut Series Office; 2006. 11/1-2. p. 391-392.
Govinda Das. Kushta Chikitsa Prakarana (Chapter 54, Verse 60). In: Shastri A, Shastri R, editors. Bhaishajya Ratnavali. 14th ed. Varanasi: Chaukhamba Sanskrit Samsthana; 2001. p. 622.
Govinda Das. Kushta Chikitsa Prakarana (Chapter 54, Verse 20). In: Shastri A, Shastri R, editors. Bhaishajya Ratnavali. 14th ed. Varanasi: Chaukhamba Sanskrit Samsthana; 2001. p. 616.
Alzohairy MA. Therapeutics role of Azadirachta indica (Neem) and its active constituents in disease prevention and treatment. Evid-Based Complement Alternat Med [Internet]. 2016 [cited 2024 Sep 23];2016:1–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791507/.
Ayalew A, Taneja P. In-vitro evaluation of phytase and neem in chicken intestinal epithelial cells. Int J Eng Appl Sci Technol. 2019 Dec 1;4(6):77–91.
Bhavamishra. Haritakyadi Varga (Chapter 6, Verse 1-26). In: Murthy KRS, editor. Bhavaprakasha. Reprint ed. Vol. I. Varanasi: Chaukhamba Krishnadas Academy; 2004. p. 159-162.
Kumar D, Arya V, Kaur R, Bhat ZA, Gupta VK, Kumar V. A review of immunomodulators in the Indian traditional health care system. J Microbiol Immunol Infect [Internet]. 2012 Jun [cited 2024 Sep 23];45(3):165–84. Available from: https://doi.org/10.1016/j.jmii.2011.09.030.
An J, Li T, Dong Y, Li Z, Huo J. Terminalia chebulanin attenuates psoriatic skin lesions via regulation of heme oxygenase-1. Cell Physiol Biochem. 2016 Jan 1;39(2):531–43.
Pandith SN. Prabhadradi Varga (Chapter 9, Verse 45). In: Sankhyadhar S, Sankhyadhar D, Chunekar KC, editors. Raj Nighantu. 1st ed. Varanasi: Chaukhamba Orientalia; 2012. p. 427.
Jayakrishna Dasa. Aushadhi Varga (Chapter 1, Verse 274). In: Sharma GP, editor. Kaiyyadeva Nighantu. 1st ed. Varanasi: Chaukhamba Orientalia; 1979. p. 174.
Chopade JV. The efficacy of Aragwadh Patra Churna with Kanji (Externally Lepa) in the management of Dadruw S.R. to Tinea Corporis. Int J Pharm Res Appl [Internet]. 2023 Feb [cited 2024 Sep 23];8(1):2261–4. Available from: https://ijcrt.org/papers/IJCRT2402140.pdf.
Tembhurne S, Gotefode SN, Lade UM. Cassia fistula as a medicinal plant. IJCRT [Internet]. 2024 [cited 2024 Sep 23];12(2):2320–882. Available from: https://ijcrt.org/papers/IJCRT2402140.pdf.
Rahmani AH. Cassia fistula Linn: potential candidate in health management. Int J Nutr Pharmacol Neurol Dis. 2015 Jul–Sep;7(3):217–224.
Shastri AD, editor. Sushruta Samhita of Maharshi Sushruta edited with Hindi commentary Ayurveda Tatwa Sanipika: Sutrasthana (Chapter 18, Verse 13). Varanasi: Chaukhamba Sanskrit Samsthana; Reprint 2016. p. 96–97.
Acharya YT. Sushruta Samhita of Sushruta, Sharira Sthana (Chapter 9, Verse 9). 8th ed. Varanasi: Chaukhamba Orientalia; 2005. p. 385.
Brunton LL. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed. Sec. XIII. New York: McGraw-Hill Publication; 2006. p. 1087.
Hirlekar PS. Shareera Tatva Darshana of Purushottama Sharma. Amravati: Saraswati Mudranalaya; 1942. p. 243.
Naldi L. Psoriasis and smoking: links and risks. Psoriasis Targets Ther. 2016 May;6:65.
